Romil Patel on Muck Rack

Romil Patel

  • Contributor and Senior Editorial Manager, M&G Investments, Freelance
London, United Kingdom
As seen in: MSN, Bloomberg News, Nature, The Telegraph, Wiley Online Library, Seeking Alpha, International Business Times (U.K.), Yahoo, Funds Europe, Funds Global Asia
I am the son of a refugee and an immigrant. Made in the EU.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Romil

Contact Romil, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study

|
By Brian L. Egleston, Raphael Steiner, Ariela Noy, Verónica Alzate Carvajal, Emeline R. Chong, Seda S. Tolu, Gaston Jean-Louis, Jennifer E Amengual, Romil Patel, Sairah Ahmed, John Sharp , Timothy Voorhees, Robert A Baiocchi, Andres Ramirez-Gamero, Jorge Castillo , Emily R. Hamburger, Imran Nizamuddin, Neha Mehta-Shah, Jose D. Sandoval-Sus, Alexandra E. Rojek, Peter A. Riedell, Niloufer Khan, Alexey B. Danilov, Paul Rubinstein, Anthony Ariotti, Gita Suneja, Charles J Milrod, Adam Olszewski, Gordon J. Smilnak, Emily Ayers, Sahaj Desai, Joanna Rhodes, Gabriella Magarelli, Tatyana Feldman, Meredith Pellon, David M. Aboulafia, William Bae, Carlos Galvez, Mehdi Hamadani, Stefan K. Barta, Matthew Hamby, Zachary A. K. Frosch, Christopher Dittus, Vinod Solipuram, Alexander Vartanov, Vineel Bhatlapenumarthi
| Nature
Abstract Plasmablastic lymphoma (PBL) is a rare, aggressive AIDS-related lymphoma observed in patients with immunosuppressed states as well as in immunocompetent individuals. We sought to determine survival outcomes, prognostic factors, and optimal treatment regimens in a large, contemporary cohort of patients with PBL in the United States. We performed a multicenter, retrospective cohort study, including 344 patients diagnosed with PBL between 2005 and 2022.
Open in Who Shared Issue with article?

TriplePoint Venture Growth: Why This 14% Yield May Be Heading For Another Cut (NYSE:TPVG)

|
By Romil Patel
| Seeking Alpha
Romil Patel 1.13K Followers Comments Summary TriplePoint Venture Growth (TPVG) trades at 0.74x book with a 14% yield, but a low 5.1% ROAA reveals a significant gap between portfolio yield and true economic returns. Unlike peers HTGC and TRIN, TPVG’s focus on pre-EBITDA companies creates "binary" risks where failures often lead to significant principal loss. PIK interest now accounts for 21% of investment income, creating "phantom" taxable income and increasing the risk of future defaults.
Open in Who Shared Issue with article?

Blackstone: The 'Deal Dam' Is Breaking And The Fee Engine Is Scaling (NYSE:BX)

|
By Romil Patel
| Seeking Alpha
Romil Patel 1.11K Followers Comments Summary Blackstone has pulled back on private credit and real estate worries, presenting a buying opportunity at a more reasonable valuation. BX's brand strength ensures continued AUM inflows, driving fee growth and performance tailwinds, even amid sector-specific headwinds. The macro setup favors asset holders, with anticipated Fed rate cuts and expansionary fiscal policy likely to put a floor on asset prices and benefit BX.
Open in Who Shared Issue with article?
See all 177 licensed articles (1,262 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Romil

Contact Romil, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified